• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨髓增殖性肿瘤中的血栓形成、微血管病和出血的病理生物学。

The pathobiology of thrombosis, microvascular disease, and hemorrhage in the myeloproliferative neoplasms.

机构信息

Department of Hematology, Zealand University Hospital, Roskilde, Denmark.

Clinic of Vascular and Endovascular Surgery, Düsseldorf, Germany; and.

出版信息

Blood. 2021 Apr 22;137(16):2152-2160. doi: 10.1182/blood.2020008109.

DOI:10.1182/blood.2020008109
PMID:33649757
Abstract

Thrombotic, vascular, and bleeding complications are the most common causes of morbidity and mortality in the Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs). In these disorders, circulating red cells, leukocytes, and platelets, as well as some vascular endothelial cells, each have abnormalities that are cell-intrinsic to the MPN driver mutations they harbor (eg, JAK2 V617F). When these cells are activated in the MPNs, their interactions with each other create a highly proadhesive and prothrombotic milieu in the circulation that predisposes patients with MPN to venous, arterial, and microvascular thrombosis and occlusive disease. Bleeding problems in the MPNs are caused by the MPN blood cell-initiated development of acquired von Willebrand disease. The inflammatory state created by MPN stem cells in their microenvironment extends systemically to amplify the clinical thrombotic tendency and, at the same time, preferentially promote further MPN stem cell clonal expansion, thereby generating a vicious cycle that favors a prothrombotic state in these diseases.

摘要

血栓形成、血管和出血并发症是费城染色体阴性骨髓增殖性肿瘤(MPN)中发病率和死亡率的最常见原因。在这些疾病中,循环中的红细胞、白细胞和血小板,以及一些血管内皮细胞,都存在与其所携带的 MPN 驱动突变(如 JAK2 V617F)内在相关的异常。当这些细胞在 MPN 中被激活时,它们彼此之间的相互作用在循环中产生了一种高度黏附和促血栓形成的环境,使 MPN 患者易患静脉、动脉和微血管血栓形成和闭塞性疾病。MPN 中的出血问题是由 MPN 血细胞引发的获得性血管性血友病发展而来的。MPN 干细胞在其微环境中产生的炎症状态会系统性地放大临床血栓形成倾向,同时优先促进进一步的 MPN 干细胞克隆扩增,从而产生一个有利于这些疾病中促血栓形成状态的恶性循环。

相似文献

1
The pathobiology of thrombosis, microvascular disease, and hemorrhage in the myeloproliferative neoplasms.骨髓增殖性肿瘤中的血栓形成、微血管病和出血的病理生物学。
Blood. 2021 Apr 22;137(16):2152-2160. doi: 10.1182/blood.2020008109.
2
Thrombotic, Vascular, and Bleeding Complications of the Myeloproliferative Neoplasms.骨髓增殖性肿瘤的血栓、血管和出血并发症。
Hematol Oncol Clin North Am. 2021 Apr;35(2):305-324. doi: 10.1016/j.hoc.2020.11.006. Epub 2021 Jan 5.
3
A systematic review and meta-analysis of the prevalence of thrombosis and bleeding at diagnosis of Philadelphia-negative myeloproliferative neoplasms.一项关于费城阴性骨髓增殖性肿瘤诊断时血栓形成和出血发生率的系统评价和荟萃分析。
BMC Cancer. 2019 Feb 28;19(1):184. doi: 10.1186/s12885-019-5387-9.
4
Platelets as Mediators of Thromboinflammation in Chronic Myeloproliferative Neoplasms.血小板在慢性骨髓增殖性肿瘤中的血栓炎症中介作用。
Front Immunol. 2019 Jun 14;10:1373. doi: 10.3389/fimmu.2019.01373. eCollection 2019.
5
Mean platelet volume and risk of thrombotic and bleeding complications in patients with Philadelphia chromosome negative myeloproliferative neoplasms.费城染色体阴性骨髓增殖性肿瘤患者的平均血小板体积与血栓形成和出血并发症风险
Blood Coagul Fibrinolysis. 2018 Apr;29(3):288-293. doi: 10.1097/MBC.0000000000000717.
6
Thrombotic and bleeding complications in classical myeloproliferative neoplasms.经典骨髓增殖性肿瘤的血栓形成和出血并发症。
Semin Thromb Hemost. 2013 Feb;39(1):101-11. doi: 10.1055/s-0032-1331153. Epub 2012 Dec 23.
7
Novel Pathophysiological Mechanisms of Thrombosis in Myeloproliferative Neoplasms.骨髓增殖性肿瘤中血栓形成的新病理生理学机制。
Curr Hematol Malig Rep. 2021 Jun;16(3):304-313. doi: 10.1007/s11899-021-00630-8. Epub 2021 Apr 19.
8
Thrombosis in myeloproliferative neoplasms with JAK2V617F mutation.JAK2V617F 突变的骨髓增殖性肿瘤中的血栓形成。
Clin Appl Thromb Hemost. 2013 Jul-Aug;19(4):374-81. doi: 10.1177/1076029612453761. Epub 2012 Jul 23.
9
The role of leukocytes in myeloproliferative neoplasm thromboinflammation.白细胞在骨髓增殖性肿瘤血栓炎症中的作用。
J Leukoc Biol. 2024 May 29;115(6):1020-1028. doi: 10.1093/jleuko/qiae071.
10
Thromboinflammation in Myeloproliferative Neoplasms (MPN)-A Puzzle Still to Be Solved.骨髓增殖性肿瘤(MPN)中的血栓炎症——一个待解决的难题。
Int J Mol Sci. 2022 Mar 16;23(6):3206. doi: 10.3390/ijms23063206.

引用本文的文献

1
Applications of microfluidic chip technology in microvascular thrombosis research.微流控芯片技术在微血管血栓形成研究中的应用。
Mikrochim Acta. 2025 May 24;192(6):371. doi: 10.1007/s00604-025-07239-1.
2
The Association Between Janus Kinase 2 and Factor V Leiden Mutations and Thrombotic Complications in Patients With Myeloproliferative Disorders: A Study From Saudi Arabia.沙特阿拉伯的一项研究:骨髓增殖性疾病患者中 Janus 激酶 2 与凝血因子 V 莱顿突变及血栓形成并发症之间的关联
Cureus. 2024 Nov 25;16(11):e74401. doi: 10.7759/cureus.74401. eCollection 2024 Nov.
3
Thrombotic, Cardiovascular, and Microvascular Complications of Myeloproliferative Neoplasms and Clonal Hematopoiesis (CHIP): A Narrative Review.
骨髓增殖性肿瘤和克隆性造血(CHIP)的血栓形成、心血管和微血管并发症:一项叙述性综述
J Clin Med. 2024 Oct 12;13(20):6084. doi: 10.3390/jcm13206084.
4
Thrombosis in myeloproliferative neoplasms: a viewpoint on its impact on myelofibrosis, mortality, and solid tumors.骨髓增殖性肿瘤中的血栓形成:对其影响骨髓纤维化、死亡率和实体瘤的观点。
Blood Cancer J. 2024 Oct 25;14(1):188. doi: 10.1038/s41408-024-01169-6.
5
Myeloproliferative Neoplasms and Dementia Risk: A Population-Based Cohort Study.骨髓增殖性肿瘤与痴呆风险:一项基于人群的队列研究。
Eur J Haematol. 2025 Jan;114(1):45-56. doi: 10.1111/ejh.14297. Epub 2024 Sep 16.
6
Increased mRNA expression for serotonin receptor 1B (HTR1B) is associated with thrombosis in BCR::ABL1-negative myeloproliferative neoplasms.血清素受体 1B(HTR1B)mRNA 表达增加与 BCR::ABL1 阴性骨髓增殖性肿瘤中的血栓形成有关。
J Cell Mol Med. 2024 Aug;28(16):e70024. doi: 10.1111/jcmm.70024.
7
Combination therapy with ruxolitinib and pegylated interferon alfa-2a in newly diagnosed patients with polycythemia vera.芦可替尼联合聚乙二醇干扰素 α-2a 治疗初诊原发性骨髓纤维化患者。
Blood Adv. 2024 Oct 22;8(20):5416-5425. doi: 10.1182/bloodadvances.2024013170.
8
JAK2-mutant clonal hematopoiesis is associated with venous thromboembolism.JAK2 突变性克隆性造血与静脉血栓栓塞相关。
Blood. 2024 Nov 14;144(20):2149-2154. doi: 10.1182/blood.2024024187.
9
Arterial Thrombosis in Patients with Cancer.癌症患者的动脉血栓形成
Cancers (Basel). 2024 Jun 17;16(12):2238. doi: 10.3390/cancers16122238.
10
Neutrophil-specific expression of JAK2-V617F or CALRmut induces distinct inflammatory profiles in myeloproliferative neoplasia.中性粒细胞特异性表达 JAK2-V617F 或 CALRmut 可导致骨髓增殖性肿瘤中不同的炎症特征。
J Hematol Oncol. 2024 Jun 9;17(1):43. doi: 10.1186/s13045-024-01562-5.